Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
PASG — Passage Bio, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2022 Earnings Call Summary

MAR 6, 2023
REVENUE
$0
EPS
-$9.40 +4.1%
FREE CASH FLOW
-$27.5M -16.3%

No summary has been written for this call yet.